Reevaluation of prognostic significance of symptoms in Hodgkin's disease
- PMID: 4052959
- DOI: 10.1002/1097-0142(19851215)56:12<2874::aid-cncr2820561227>3.0.co;2-2
Reevaluation of prognostic significance of symptoms in Hodgkin's disease
Abstract
The prognostic value--at diagnosis--of fever, sweating and weight loss, which enter the Ann Arbor B category, and of pruritus, whose influence on survival is still debated, were systematically reevaluated in 635 patients with Hodgkin's disease, observed between 1972 and 1982. By means of multivariate analysis an intrinsic, more negative prognostic value was demonstrated for each of the following symptoms: fever over 38 degrees C, weight loss more than 10% of body weight in the 6 months before admission, and severe pruritus, which is defined as being generalized, causing multiple excoriations and resisting local and systemic antipruritics. Patients with the mild counterparts of these symptoms, as well as sweats, were found to have a survival rate quite comparable with that of fully asymptomatic patients. A rearrangement of the Ann Arbor B constitutional symptoms which would replace sweats with severe pruritus might be more correct and more suitable for better selecting the patients who require more aggressive therapy.
Similar articles
-
Severe pruritus should be a B-symptom in Hodgkin's disease.Cancer. 1983 May 15;51(10):1934-6. doi: 10.1002/1097-0142(19830515)51:10<1934::aid-cncr2820511030>3.0.co;2-r. Cancer. 1983. PMID: 6831358
-
Prognostic importance of pruritus in Hodgkin's disease.JAMA. 1978 Dec 15;240(25):2738-40. JAMA. 1978. PMID: 713007
-
[Generic symptoms of Hodgkin's disease in relation to other prognostic criteries (author's transl)].Strahlentherapie. 1978 Nov;154(11):758-65. Strahlentherapie. 1978. PMID: 715807 German.
-
[Two cases of severe pruritus revealing Hodgkin's disease in children].Ann Dermatol Venereol. 2014 Dec;141(12):765-8. doi: 10.1016/j.annder.2014.09.004. Epub 2014 Oct 23. Ann Dermatol Venereol. 2014. PMID: 25433928 Review. French.
-
Prognostic factors in advanced Hodgkin's disease: problems and pitfalls. Towards an international prognostic index.Leuk Lymphoma. 1995;15 Suppl 1:23-4. doi: 10.3109/10428199509052700. Leuk Lymphoma. 1995. PMID: 7767254 Review. No abstract available.
Cited by
-
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.Blood Adv. 2021 Mar 23;5(6):1671-1681. doi: 10.1182/bloodadvances.2020003664. Blood Adv. 2021. PMID: 33720338 Free PMC article.
-
Insights into uveitis from Brentuximab vedotin in refractory Hodgkin's lymphoma: a case report and brief review.Front Oncol. 2024 Aug 5;14:1419145. doi: 10.3389/fonc.2024.1419145. eCollection 2024. Front Oncol. 2024. PMID: 39161379 Free PMC article.
-
Checkpoint CD47 expression in classical Hodgkin lymphoma.Br J Haematol. 2022 Jun;197(5):580-589. doi: 10.1111/bjh.18137. Epub 2022 Mar 17. Br J Haematol. 2022. PMID: 35301709 Free PMC article.
-
Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy.Adv Radiat Oncol. 2024 Sep 24;9(12):101636. doi: 10.1016/j.adro.2024.101636. eCollection 2024 Dec. Adv Radiat Oncol. 2024. PMID: 39524528 Free PMC article.
-
Hodgkin lymphoma: A review and update on recent progress.CA Cancer J Clin. 2018 Mar;68(2):116-132. doi: 10.3322/caac.21438. Epub 2017 Dec 1. CA Cancer J Clin. 2018. PMID: 29194581 Free PMC article. Review.